Efficacy and safety of SGLT2 inhibitors in individuals with type 1 diabetes under continuous subcutaneous insulin infusion: a real-world study
, , , , , , , et | 10 août 2023
Publié en ligne: 10 août 2023
Pages: 144 - 151
© 2023 Vania Benido Silva et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.